CD8A and neoplasm: Despite the success observed in these studies and the knowledge that the co-transfer of helper immune subsets, together with CD8+ T cells, generates a greater anti-tumor response, there have been no studies investigating the anti-tumor potential of different combinations of CAR-expressing leukocyte subsets.